Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Mitomycin C: small, fast and deadly (but very selective)

¹Department of Chemistry, Hunter College, City University of New York, NY 10021, USA.

Chemistry & Biology

|September 1, 1995

Summary

Mitomycin C crosslinks DNA at the CpG sequence with high efficiency. New findings reveal how this occurs, potentially enabling the design of novel DNA-crosslinking agents targeting other sequences.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Reductive activation of mitomycin A by thiols.

Organic letters·2001

Same author

Solution structure of a guanine-N7-linked complex of the mitomycin C metabolite 2,7-diaminomitosene and DNA. Basis of sequence selectivity.

Biochemistry·2001

Same author

Selective activation of mitomycin A by thiols to form DNA cross-links and monoadducts: biochemical basis for the modulation of mitomycin cytotoxicity by the quinone redox potential.

Journal of medicinal chemistry·2001

Same author

Bioreductive metabolism of mitomycin C in EMT6 mouse mammary tumor cells: cytotoxic and non-cytotoxic pathways, leading to different types of DNA adducts. The effect of dicumarol.

Biochemical pharmacology·2001

Same author

Structure of adduct X, the last unknown of the six major DNA adducts of mitomycin C formed in EMT6 mouse mammary tumor cells.

Chemical research in toxicology·2000

Same author

Mitomycin C linked to DNA minor groove binding agents: synthesis, reductive activation, DNA binding and cross-linking properties and in vitro antitumor activity.

Bioorganic & medicinal chemistry·2000

Area of Science:

Biochemistry
Molecular Biology
Medicinal Chemistry

Background:

Mitomycin C is a crucial antitumor drug and antibiotic.
It exhibits remarkable efficiency and specificity in crosslinking DNA, particularly at the CpG sequence.

Purpose of the Study:

To elucidate the mechanism by which mitomycin C crosslinks DNA.
To understand the basis for its absolute sequence specificity for CpG sites.
To explore the potential for designing new agents based on these findings.

Main Methods:

The study likely involved biochemical assays and structural analyses to investigate DNA-protein interactions.
Advanced molecular modeling or computational chemistry may have been employed.

Main Results:

Detailed mechanisms of mitomycin C-induced DNA crosslinking have been revealed.
The complete sequence specificity for CpG has been explained at a molecular level.

Conclusions:

The understanding of mitomycin C's DNA crosslinking mechanism and specificity is advanced.
This knowledge may facilitate the rational design of novel therapeutic agents with tailored DNA sequence targeting capabilities.

Related Experiment Videos